Belgian pharmaceutical firm keen on cooperation with Iran

Tehran, Nov 14, IRNA – The Sales Manager of the Belgian Coris BioConcept Company said his company is seeking cooperation with Iran in selling products and starting laboratory and research activities with Iranian pharmaceutical firms and research centers. Jean-Marie Hoornaert who had a trip to Iran to take part in Iran-Belgium Trade Conference and B2B negotiations, told IRNA that Iran's 80-million market which has become available after the implementation of JCPOA can't be ignored and Belgium is seeking for long-term trade ties with Iran. Hoornaert said that Coris BioConcept had no relations with Iran during sanctions era but now is ready to have cooperation in introducing new products. Deputy Minister of Industry, Mine and Trade Mojtaba Khosro Taj said that the trade exchange volume of Iran and Belgium is 300-400 million dollars per year and attempts should be made to boost the figure to over $1b. Coris BioConcept is a middle-sized company (SME) specialized in developing, manufacturing and marketing rapid diagnostic tests. Iran-Belgium Trade Conference was held with the attendance of some 140 Belgian firms on October 30 in Tehran, Iran. 1378/IRNA